heart failure glp-1 The effect of receptor agonists on cardiac remodeling in patients with preserved and reduced ejection fraction: a systematic review and meta-analysis | Heart Failure Reviews GLP-1 Agonist Therapy for Advanced
Description
If you feel muted on your GLP-1, it might be worth investigating other ways to recalibrate your relationship with dopamine
The paper explores the science at the intersection of metabolic hormones and precision nutrition and multi-target therapies, like tirzepatide and retatrutide
Weight Loss Many patients experience weight loss while taking Tirzepatide
Paulus WJ, Tschpe C (2013) A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
In addition, all favourable cardiometabolic changes were projected to return to baseline levels 1.4 years after stopping treatment
24 In a post hoc analysis by Pitt et al., among those enrolled with HFrEF, sotagliflozin led to a 22% risk reduction of CV death or HF-related event (HF hospitalisation or urgent care visit) occurring within 90 and 30 days after discharge for worsening HF hospitalisation, emphasising the importance of starting SGLT2I treatment before discharge
